Iterum Therapeutics Announces Filing of Winding Up Petition
Iterum Therapeutics plc has filed a winding up petition in the Irish High Court, moving towards liquidation due to insufficient cash resources, inability to comply with Nasdaq listing requirements, lack of viable strategic alternatives, and ongoing financial pressures from operating costs including commercialization of ORLYNVAH™. The company antici…